Brief: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform And Assets, Driving Pipeline Expansion And Advancing Global Partnership With UCB Through Acquired Rights
09/12/2025 13:04
Dec 9 (Reuters) - Lee's Pharmaceutical Holdings Ltd 0950.HK: LEE'S PHARMACEUTICAL HOLDINGS LIMITED ACQUIRES STACCATO® ONE BREATH TECHNOLOGY® PLATFORM AND ASSETS, DRIVING PIPELINE EXPANSION AND ADVANCING GLOBAL PARTNERSHIP WITH UCB THROUGH ACQUIRED RIGHTS LEE'S PHARMACEUTICAL HOLDINGS LTD: CO TOGETHER WITH NPI MAY RECEIVE MILESTONE PAYMENTS TOTALLING UP TO US$60.5 MILLION Source text: ID:nPn8wCPLqa Further company coverage: 0950.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals